Trial Profile
Clinical Trials Insight: 700031239
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 06 Mar 2008
Price :
$35
*
At a glance
- Drugs UNBS 5162 (Primary)
- Indications Lymphoma; Solid tumours
- Focus Adverse reactions
- Sponsors Unibioscreen
- 06 Mar 2008 New trial record.